ERCC6L facilitates the onset of mammary neoplasia and promotes the high malignance of breast cancer by accelerating the cell cycle

BACKGROUND: Breast cancer (BC) is the leading cause of morbidity and the second leading cause of death among female malignant tumors. Although available drugs have been approved for the corresponding breast cancer subtypes (ER-positive, HER2(+)) currently, there are still no effective targeted drugs...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Hong, Zhen, Xiangjin, Yang, Yihui, Zhang, Yizhi, Zhang, Sen, Hao, Yue, Du, Guanhua, Wang, Hongquan, Zhang, Bailin, Li, Wan, Wang, Jinhua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10478442/
https://www.ncbi.nlm.nih.gov/pubmed/37667329
http://dx.doi.org/10.1186/s13046-023-02806-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10478442/
https://www.ncbi.nlm.nih.gov/pubmed/37667329
http://dx.doi.org/10.1186/s13046-023-02806-x

Ejemplares similares